Cite
Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.
MLA
Wedgeworth, E., et al. “Propranolol in the Treatment of Infantile Haemangiomas: Lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce Survey.” The British Journal of Dermatology, vol. 174, no. 3, Mar. 2016, pp. 594–601. EBSCOhost, https://doi.org/10.1111/bjd.14233.
APA
Wedgeworth, E., Glover, M., Irvine, A. D., Neri, I., Baselga, E., Clayton, T. H., Beattie, P. E., Bjerre, J. V., Burrows, N. P., Foelster-Holst, R., Hedelund, L., Hernandez-Martin, A., Audrain, H., Bhate, K., Brown, S. J., Baryschpolec, S., Darne, S., Durack, A., Dvorakova, V., … Flohr, C. (2016). Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey. The British Journal of Dermatology, 174(3), 594–601. https://doi.org/10.1111/bjd.14233
Chicago
Wedgeworth, E, M Glover, A D Irvine, I Neri, E Baselga, T H Clayton, P E Beattie, et al. 2016. “Propranolol in the Treatment of Infantile Haemangiomas: Lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce Survey.” The British Journal of Dermatology 174 (3): 594–601. doi:10.1111/bjd.14233.